Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Myelodysplastic syndrome with excess blasts
Myelodysplastic syndrome with excess blasts-2
A myelodysplastic syndrome defined by 10-19% blasts in the bone marrow or 5-19% blasts in the blood and <10% blasts in the bone marrow. Approximately 33% of cases progress to acute leukemia. The prognosis is usually poor. (WHO)
This condition has no sub-types.